Themes explored in the case below discharged yesterday:
Diagnostic uncertainty:
Clinical features suggestive of acute meningitis in a patient of metabolic syn with trunkal obesity, parotidomegaly etc as part of the metabolic phenotype.
Hemorrhagic lumbar puncture inconclusive
Cranial MRI suggestive of blood or pus, interpreted due to REDUCED DIFFUSION IN TRIGONES OF B/L LATERAL
VENTRICLES as ? CHRONIC INTRA VENTRICULAR BLOOD COLLECTION OR PUS
Past traumatic brain injury 8 years back for which craniectomy was done and similar episode suggestive of meningitis 4 years back.
Therapeutic uncertainty:
Empirical pharmacological and non pharmacological interventions
EMR summary (with defensive medicine themes due to the diagnostic and therapeutic uncertainty):
Age/Gender : 45 Years/Male
Address :
Discharge Type: Referred
Admission Date: 27/01/2025 04:59 AM
Diagnosis:
Discharge Type: Referred
Admission Date: 27/01/2025 04:59 AM
Diagnosis:
ALTERED SENSORIUM SECONDARY TO ?SEPTIC ENCEPHALOPATHY B/L FLUID FILLED LATERAL VENTRICLES [?BLOOD ?PUS]
CHRONIC INFARCTS IN LEFT FRONTAL REGION S/P CRANIOTOMY
K/C/O HTN, DM II
Case History and Clinical Findings PATIENT WAS BROUGHT TO CASUALTY WITH H/O FEVER SINCE 2 DAYS
HEADACHE SINCE 7 DAYS
ALTERED SENSORIUM SINCE YESTERDAY 5PM C/O SLURRING OF SPEECH YESTERDAY
C/O B/L LOWER LIMB WEAKNESS SINCE YESTERDAY HISTORY OF PRESENT ILLNESS
PATIENT WAS APPARENTLY ASYMPTOMATIC 2 DAYS BACK THEN HE DEVELOPED FEVER HIGH GRADE WITH CHILLS, INTERMITTENT, ASSOCIATED WITH HEADACHE - DIFFUSE. PATIENT WAS ABLE TO DO HIS REGULAR ACTIVITIES UPTO YESTERDAY EVENING, THEN
DEVELOPED GIDDINESS, NOT ASSOCIATED WITH LOSS OF CONSCIOUSNESS,
INVOLUNTARY MOVEMENTS, FROTHY, TONGUE BITE. PASSED URINE CONSCIOUSLY AS HE WAS UNABLE TO MOVE DUE TO GIDDINESS. TAKEN TO OUTSIDE HOSPITAL, TALKED TO ATTENDERS AFTER HOSPITAL ADMISSION, THEN DEVELOPED ALTERED SENSORIUM
NO H/O VOMITINGS, LOOSE STOOLS
PAST HISTORY
H/O SIMILAR COMPLAINTS IN THE PAST
K/C/O HTN SINCE 10 YRS ON TELMA H 40/125, CINOD 10 MG K/C/O TYPE II DM SINCE 10 YRS ON METFORMIN 500MG OD
PERSONAL HISTORY :
OCCUPATION : GOVT EMPLOYEE NORMAL APPETITE BOWEL:REGULAR
MICTURITION : NORMAL NO KNOWN ALLERGIES
ADDICTIONS : ALCOHOLIC LAST INTAKE 5 DAYS BACK SMOKING NO
BETEL LEAF(PAN) - NO
FAMILY HISTORY : NOT SIGNIFICANT
GENERAL EXAMINATION :
NO PALLOR, ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY, EDEMA BP: 140/90 MMHG
PR: 89 BPM
RR: 20 CPM
SPO2: 99%
GRBS- 301 mg/dL SYSTEMIC EXAMINATION
CVS- SI, S2 HEARD, NO THRILLS, NO MURMURS RS- BAE +, NVBS
ABDOMEN- SOFT, NON TENDER
CNS- PATIENT IS DROWSY AROUSABLE SPEECH - SLURRED
CRANIAL NERVES - NORMAL SENSORY SYSTEM - NOT ELICITED GCS - E2V3M3
MOTOR SYSTEM - RT LT TONE UL NORMAL NORMAL
LL INCREASED INCREASED POWER CANT BE ELICITED RIGHT LEFT
REFLEXES B 2+ 2+
T 2+ 2+ S - -
K - -
A - -
P FLEXION FLEXION
NEUROSURGERY REFERRAL DONE ON 27/1/25,I/V/O CHRONIC BLOOD COLLECTION IN LATERAL VENTRICLES ON MRI BRAIN, ADVISED NO ACTIVE NEUROSURGICAL INTERVENTION NEEDED AS OF NOW. CONSIDER NEUROPHYSICIAN OPINION.
OPHTHALMOLOGY REFERRAL DONE ON 27/1/25 I/V/O RAISED ICT CHANGES, ADVISED NO RAISED ICP CHANGES NOTED AS OF NOW
Investigation
CSF: Hemorrhagic (microscopic findings and biochemical analysis missing from the EMR summary)
COMPLETE URINE EXAMINATION (CUE) 27-01-2025 05:50:AM
COLOUR Pale yellow APPEARANCE Clear
REACTION Acidic SP.GRAVITY 1.010 ALBUMIN + SUGAR +++
BILE SALTS Nil BILE PIGMENTS Nil PUS CELLS 3-6
EPITHELIAL CELLS 2-4 RED BLOOD CELLS Nil CRYSTALS Nil
CASTS Nil
AMORPHOUS DEPOSITS Absent OTHERS Nil
LIVER FUNCTION TEST (LFT) 27-01-2025 05:50:AM
Total Bilurubin 3.24 mg/dl 1-0 mg/dl
Direct Bilurubin 0.76 mg/dl 0.2-0.0 mg/dl
SGOT(AST) 21 IU/L 35-0 IU/L
SGPT(ALT) 19 IU/L 45-0 IU/L
ALKALINE PHOSPHATASE 97 IU/L 128-53 IU/L
TOTAL PROTEINS 7.3 gm/dl 8.3-6.4 gm/dl
ALBUMIN 4.2 gm/dl 5.2-3.5 gm/dl
A/G RATIO 1.36
BLOOD UREA 27-01-2025 05:50:AM 46 mg/dl 42-12 mg/dl
SERUM CREATININE 27-01-2025 05:50:AM 1.4 mg/dl 1.3-0.9 mg/dl SERUM ELECTROLYTES (Na, K, C l) 27-01-2025 05:50:AM
SODIUM 130 mmol/L 145-136 mmol/L
POTASSIUM 3.4 mmol/L 5.1-3.5 mmol/L
CHLORIDE 94 mmol/L 98-107 mmol/L
ABG 27-01-2025 05:57:AM
PH 7.40
PCO2 27.0
PO2 103
HCO3 16.4
St.HCO3 19.0
BEB -6.7
BEecf -7.5
TCO2 33.1
O2 Sat 97.8
O2 Count 33.1
HBsAg-RAPID 27-01-2025 06:05:AM Negative
Anti HCV Antibodies - RAPID 27-01-2025 06:05:AM Non Reactive HEMOGRAM
HAEMOGLOBIN 12.7gm/dl
TOTAL COUNT 23,000cells/cumm NEUTROPHILS 87%
LYMPHOCYTES 03%
EOSINOPHILS 01%
MONOCYTES 09% BASOPHILS00% PCV 36.1vol %
M C V87.6fl M C H 30.9pg
M C H C 35.3% RDW-CV 13.5% RDW-SD 47.1fl
RBC COUNT 4.12 millions/cumm PLATELET COUNT 1.99 lakhs/cu.mm RBC Normocytic normochromic
WBC Increased in count with Neutrophilia PLATELETS Adeqaute
HEMOPARASITES No hemoparasites seen
IMPRESSIONNormocytic normochromic blood picture with Neutrophilic leukocytosis
MRI BRAIN PLAIN
CRANIOTOMY CHANGES ARE SEEN IN THE RIGHT SUPERIOR PARIETAL REGION. CRANIOTOMY CHANGES ARE SEEN IN THE RIGHT FRONTAL AND INFERIOR PARIETAL REGION
SMALL AREA OF REDUCED DIFFUSION IS SEEN IN THE LEFT CEREBELLAR HEMISPHERE MEASURING 11MM S/O CYTOXIC EDEMA COULD BE DUE TO INFECTION OR ACUTE INFARCT FLUID FILLED LEVELS WITH REDUCED DIFFUSION IN TRIGONES OF B/L LATERAL
VENTRICLES- COULD BE - CHRONIC INTRA VENTRICULAR BLOOD COLLECTION OR PUS
COLLECTION
MODERATE SIZED CHRONIC INFARCT IN LEFT INFERIOR TEMPORAL REGION
SMALL AREAS OF NEUROPARENCHYMAL LOSS WITH SURROUNDING GLIOSIS IN LEFT SUPERIOR TEMPORAL LOBE, LEFT ANTERIOR FRONTAL LOBE, RIGHT POSTERIOR FRONTAL LOBE - S/O CHRONIC INFARCT
BASAL GANGLIA AND THALAMI ARE NORMAL
CRANIO VERTEBRAL AND CERVICO MEDULLARY JUNCTIONS ARE NORMAL SELLA, PITUITARY AND PARASELLAR REGIONS ARE NORMAL
STALK AND HYPOTHALAMUS ARE NORMAL. POSTERIOR PITUITARY BRIGHT SPOT IS NORMAL
2D ECHO NO RWMA
TRIVIAL TR/AR/MR NO PAH
SCLEROTIC AV : NO AS/MS IAS- INTACT EF = 58% RVSP = 32+5 = 37MMHG GOOD LV SYSTOLIC FUNCTIONS
NO DIASTOLIC DYSFUNCTYION IVC SIZE [1.40 CM] COLLAPSING NO PE , LV CLOTS
Treatment Given(Enter only Generic Name)
1.] IV FLUIDS NS @ 100ML/HR WITH 1AMP OPTINEURON
2.] INJ DEXAMETHASONE 6MG IV/TID
3.] INJ MONOCEF 2GM STAT >2GM IV BD
4.] INJ DOXYCYCLIN 100MG IV/BD
5.] INJ LEVIPIL 500MG IV/BD
6.] INJ THIAMINE 600MG IV/STAT > 200MG IV/BD
7.] INJ PAN 40MG IV/OD
8.]INJ ZOFER 4MG IV/SOS
9.]INJ PCM 1GM IV/SOS
10.]INJ HAI S/C TID ACC TO GRBS
11.] GRBS 7 POINT PROFILE MONITORING
12.] MONITOR VITALS 2ND HRLY
13.] RT FEEDS - 100ML MILK 4TH HRLY
- 50ML WATER 2ND HRLY
14.] INJ.VANCOMYCIN 2GM IV/BD
15.] INJ NEOMOL 1GM /SOS
Advice at Discharge
REFER TO HIGHER CENTRE
THE PATIENT Attenders HAS BEEN EXPLAINED ABOUT THE CONDITION OF THE PATIENT IN THEIR OWN UNDERSTANDABLE LANGUAGE AND REQUIREMENT OF IMMEDIATE NEUROPHYSICIAN AND NEUROSURGERY INTERVENTION AS ADVISED BY NEUROPHYSICIAN AND IS BEING REFERED TO HIGHER CENTRE I/V/O SAME.
Discharge Date Date: 27/1/25 Ward:ICU
Unit: V
Unit: V
Here's a summary, key words, thematic analysis with coding, categorization, and learning insights from the provided case report:
Summary
A 45-year-old male patient presented with fever, headache, altered sensorium, and slurred speech. He had a history of metabolic syndrome, hypertension, and type 2 diabetes. The patient underwent various investigations, including MRI brain, which showed chronic blood collection or pus in the lateral ventricles. He was treated with empirical antibiotics, antifungals, and supportive care. The patient was discharged with advice to seek higher center care for neurophysician and neurosurgery intervention.
Key Words
1. Altered sensorium
2. Metabolic syndrome
3. Meningitis
4. Encephalopathy
5. Diagnostic uncertainty
6. Therapeutic uncertainty
7. Empirical treatment
8. Neuroimaging
9. Chronic blood collection
10. Pus collection
Thematic Analysis with Coding
1. *Diagnostic Uncertainty* (DU): The case highlights the challenges in diagnosing altered sensorium, with multiple possible causes, including meningitis, encephalopathy, and metabolic disturbances.
2. *Therapeutic Uncertainty* (TU): The treatment approach was empirical, with a broad-spectrum antibiotic and antifungal coverage, due to the uncertainty surrounding the underlying cause.
3. *Complex Patient Profile* (CPP): The patient's metabolic syndrome, hypertension, and type 2 diabetes complicated the diagnosis and treatment.
4. *Neuroimaging Findings* (NIF): The MRI brain revealed chronic blood collection or pus in the lateral ventricles, which guided the treatment approach.
5. *Multidisciplinary Care* (MDC): The case emphasizes the need for collaboration between healthcare professionals, including neurologists, neurosurgeons, and intensivists.
Categorization
1. *Clinical Presentation*: Altered sensorium, fever, headache, and slurred speech
2. *Diagnostic Approach*: Neuroimaging (MRI brain), laboratory investigations (blood cultures, CSF analysis)
3. *Therapeutic Approach*: Empirical antibiotics, antifungals, and supportive care
4. *Patient Profile*: Metabolic syndrome, hypertension, type 2 diabetes
Learning Insights
1. *Diagnostic uncertainty*: Altered sensorium can have multiple causes, and a thorough diagnostic approach is essential.
2. *Empirical treatment*: In cases of diagnostic uncertainty, empirical treatment with broad-spectrum antibiotics and antifungals may be necessary.
3. *Multidisciplinary care*: Collaboration between healthcare professionals from different specialties is crucial in managing complex patients.
4. *Neuroimaging*: MRI brain can provide valuable information in diagnosing and managing altered sensorium.
5. *Patient education*: Educating patients and their families about the importance of seeking higher center care and adhering to treatment plans is essential.
Past data on the NKP Altered sensorium outcomes project: